Citations

Showing 10 of 108152 citations.

Health systems science education: The new post-Flexner professionalism for the 21st century
Borkan, Jeffrey, Hammoud, Maya M. , Oyler, Julie , Lawson, Luan , Starr, Stephanie R. , Gonzalo, Jed D. , Borkan, Jeffrey M , Lawson, Luan , Nelson, Elizabeth A.

Mayo Clinic

Medical Teacher | July 22, 2021 | Volume: 43 | Issue: sup2 | Pages: S25-S31

10.1080/0142159x.2021.1924366 | PMID 34291713 Get It

Biomechanical evaluation of an intramedullary clavicle screw in simple oblique and butterfly wedge fractures
Kunkle, Bryce , Campbell, Joel R., Kissenberth, Michael J. , Tokish, John M. , Kunkle, Bryce F , DesJardins, John D. , Campbell, Joel R, Eichinger, Josef Karl , Shaw, Kenneth Aaron , Parada, Stephen A.

Mayo Clinic

Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine | July 22, 2021 | Volume: 235 | Issue: 11 | Pages: 1257-1264

10.1177/09544119211031052 | PMID 34289763 Get It

This biomechanical study evaluates the performance of a solid titanium-alloy intra-medullary ( IM) clavicular screw in torsion and cantilever bending in cadaveric clavicle specimens with simulated simple oblique and butterfly wedge midshaft fractures. Thirty-two fresh-frozen male clavicles were sorted into six experimental groups: Torsion Control, Torsion Simple Oblique Fracture, Torsion Butterfly Wedge Fracture, Bending Control, Bending Simple Oblique Fracture, and Bending Butterfly Wedge Fracture. The experimental groups were controlled for density, length, diameter, and laterality. All other samples were osteotomy-induced and implanted with a single 90 mm × 3 mm clavicle screw. All groups were tested to physiologically relevant cutoff points in torsion or bending. There were no statistically significant differences in the performance of the oblique and butterfly wedge fracture models for any torsion or bend testing measures, including maximum torsional resistance ( p = 0.66), torsional stiffness ( p = 0.51), maximum bending moment ( p = 0.43), or bending stiffness ( p = 0.73). Torsional testing of samples in the direction of thread tightening tended to be stronger than samples tested in loosening, with all groups either approaching or achieving statistical significance. There were no significant differences between the simple oblique or the butterfly-wedge fracture groups for any of the tested parameters, suggesting that there is no difference in the gross biomechanical properties of the bone-implant construct when the IM clavicle screw is used in either a simple midshaft fracture pattern or a more complex butterfly wedge fracture pattern.
Non‐motor phenotypic subgroups in adult‐onset idiopathic, isolated, focal cervical dystonia
Wadon, Megan E. , Bailey, Grace , Yılmaz, Zehra, Hubbard, Emily , Alsaeed, Meshari , McLauchlan, Duncan , Barbano, Richard L. , Marsh, Laura , Fox, Susan H. , Rodriguez, Ramon L. , Comella, Cynthia , Reich, Stephen G. , Severt, William, Robinson, Amy, Factor, Stewart Alan , Adler, Charles H. , Goetz, Christopher G. , Perlmutter, Joel S. , Jinnah, H. A. , Harding, Katharine E , Sandor, Cynthia , Peall, Kathryn J.

Mayo Clinic

Brain and Behavior | July 21, 2021 | Volume: 11 | Issue: 8 | Pages: No page available

10.1002/brb3.2292 | PMID 34291595 Get It

Abstract Background : Non‐motor symptoms are well established phenotypic components of adult‐onset idiopathic, isolated, focal cervical dystonia (AOIFCD). However, improved understanding of their clinical heterogeneity is needed to better target therapeutic intervention. Here, we examine non‐motor phenotypic features to identify possible AOIFCD subgroups. Methods : Participants diagnosed with AOIFCD were recruited via specialist neurology clinics (dystonia wales: n = 114, dystonia coalition: n = 183). Non‐motor assessment included psychiatric symptoms, pain, sleep disturbance, and quality of life, assessed using self‐completed questionnaires or face‐to‐face assessment. Both cohorts were analyzed independently using Cluster, and Bayesian multiple mixed model phenotype analyses to investigate the relationship between non‐motor symptoms and determine evidence of phenotypic subgroups. Results : Independent cluster analysis of the two cohorts suggests two predominant phenotypic subgroups, one consisting of approximately a third of participants in both cohorts, experiencing increased levels of depression, anxiety, sleep impairment, and pain catastrophizing, as well as, decreased quality of life. The Bayesian approach reinforced this with the primary axis, which explained the majority of the variance, in each cohort being associated with psychiatric symptomology, and also sleep impairment and pain catastrophizing in the Dystonia Wales cohort. Conclusions : Non‐motor symptoms accompanying AOIFCD parse into two predominant phenotypic sub‐groups, with differences in psychiatric symptoms, pain catastrophizing, sleep quality, and quality of life. Improved understanding of these symptom groups will enable better targeted pathophysiological investigation and future therapeutic intervention.
Single‐neuron correlate of epilepsy‐related cognitive deficits in visual recognition memory in right mesial temporal lobe
Lee, Seung Joon , Beam, Danielle , Paul, Lynn K. , Chandravadia, Nand, Reed, Chrystal M. , Chung, Jeffrey M., Ross, Ian B., Lee, Seung J, Rutishauser, Ueli , Gómez-Palacio-Schjetnan, Andrea , Valiante, Taufik A. , Mamelak, Adam N.

Mayo Clinic

Epilepsia | July 21, 2021 | Volume: 62 | Issue: 9 | Pages: 2082-2093

10.1111/epi.17010 | PMID 34289113 Get It

AbstractObjectiveImpaired memory is a common comorbidity of refractory temporal lobe epilepsy (TLE) and often perceived by patients as more problematic than the seizures themselves. The objective of this study is to understand what the relationship of these behavioral impairments is to the underlying pathophysiology, as there are currently no treatments for these deficits, and it remains unknown what circuits are affected.MethodsWe recorded single neurons in the medial temporal lobes (MTLs) of 62 patients (37 with refractory TLE) who performed a visual recognition memory task to characterize the relationship between behavior, tuning, and anatomical location of memory selective and visually selective neurons.ResultsSubjects with a seizure onset zone (SOZ) in the right but not left MTL demonstrated impaired ability to recollect as indicated by the degree of asymmetry of the receiver operating characteristic curve. Of the 1973 recorded neurons, 159 were memory selective (MS) and 366 were visually selective (VS) category cells. The responses of MS neurons located within right but not left MTL SOZs were impaired during high‐confidence retrieval trials, mirroring the behavioral deficit seen both in our task and in standardized neuropsychological tests. In contrast, responses of VS neurons were unimpaired in both left and right MTL SOZs. Our findings show that neuronal dysfunction within SOZs in the MTL was specific to a functional cell type and behavior, whereas other cell types respond normally even within the SOZ. We show behavioral metrics that detect right MTL SOZ‐related deficits and identify a neuronal correlate of this impairment.SignificanceTogether, these findings show that single‐cell responses can be used to assess the causal effects of local circuit disruption by an SOZ in the MTL, and establish a neural correlate of cognitive impairment due to epilepsy that can be used as a biomarker to assess the efficacy of novel treatments.
Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon Cancer
Sinicrope, Frank A. , Shi, Qian , Smyrk, Thomas C. , Goldberg, Richard M. , Cohen, Steven J., Kahlenberg, Morton S., Nair, Suresh , Shield, Anthony F, Jahagirdar, Balkrishna, Foster, Nathan R. , Pollak, Michaël , Nair, Suresh , Jacobson, Sawyer B, Pollak, Michael N , Sinicrope, Frank A , Shi, Qian , Gill, Sharlene , Jacobson, Sawyer , Alberts, Steven R.

Mayo Clinic

JNCI Cancer Spectrum | July 21, 2021 | Volume: 5 | Issue: 5 | Pages: No page available

10.1093/jncics/pkab070 | PMID 34485815 Get It

AbstractBackgroundAdipocyte-derived adiponectin may play a role in the host inflammatory response to cancer. We examined the association of plasma adiponectin with the density of tumor-infiltrating lymphocytes (TILs) in colon cancers and with vitamin D, clinicopathological features, and patient survival.MethodsPlasma adiponectin and 25-hydroxyvitamin D [25(OH)D] were analyzed by radioimmunoassay in 600 patients with stage III colon cancer who received FOLFOX-based adjuvant chemotherapy (NCCTG N0147 [Alliance]). TIL densities were determined in histopathological sections. Associations with disease-free survival (DFS), time to recurrence, and overall survival were evaluated by multivariable Cox regression adjusting for potential confounders (ie, body mass index, race, TILs, and N stage). All statistical tests were 2-sided.ResultsWe found a statistically significant reduction in adiponectin, but not 25(OH)D, levels in tumors with high vs low TIL densities (median = 6845 vs 8984 ng/mL; P = .04). A statistically significant reduction in adiponectin was also observed in obese (body mass index >30 kg/m2) vs nonobese patients (median = 6608 vs 12 351 ng/mL; P < .001), in men vs women (median = 8185 vs 11 567 ng/mL; P < .001), in Blacks vs Whites or Asians (median = 6412 vs 8847 vs 7858 ng/mL; P < .03), and in those with fewer lymph node metastases (N1 vs N2: median = 7768 vs 9253 ng/mL; P = .01). Insufficiency of 25(OH)D (<30 ng/mL) was detected in 291 (48.5%) patients. In multivariable analyses, neither adiponectin nor 25(OH)D were associated with a statistically significant difference in DFS, overall survival , or time to recurrence in models adjusted for potential confounders. We found a statistically significant association of TILs with prognosis, yet no such interaction was observed for the association of adiponectin with TILs for DFS.ConclusionsLower circulating adiponectin levels were associated with a statistically significant increase in TIL densities in colon cancers, indicating an enhanced antitumor immune response. In contrast to TILs, neither adiponectin nor 25(OH)D was independently prognostic.
Cell fate conversion prediction by group sparse optimization method utilizing single-cell and bulk OMICs data
Qin, Jing , Yao, Jen‐Chih , Leung, Ricky Wai Tak , Zhou, Yongqiang, Qin, Yiming , Wang, Junwen , Wang, Junwen , Qin, Jing , Hu, Yaohua

Mayo Clinic

Briefings in Bioinformatics | July 21, 2021 | Volume: 22 | Issue: 6 | Pages: No page available

10.1093/bib/bbab311 | PMID 34374760 Get It

Abstract Cell fate conversion by overexpressing defined factors is a powerful tool in regenerative medicine. However, identifying key factors for cell fate conversion requires laborious experimental efforts; thus, many of such conversions have not been achieved yet. Nevertheless, cell fate conversions found in many published studies were incomplete as the expression of important gene sets could not be manipulated thoroughly. Therefore, the identification of master transcription factors for complete and efficient conversion is crucial to render this technology more applicable clinically. In the past decade, systematic analyses on various single-cell and bulk OMICs data have uncovered numerous gene regulatory mechanisms, and made it possible to predict master gene regulators during cell fate conversion. By virtue of the sparse structure of master transcription factors and the group structure of their simultaneous regulatory effects on the cell fate conversion process, this study introduces a novel computational method predicting master transcription factors based on group sparse optimization technique integrating data from multi-OMICs levels, which can be applicable to both single-cell and bulk OMICs data with a high tolerance of data sparsity. When it is compared with current prediction methods by cross-referencing published and validated master transcription factors, it possesses superior performance. In short, this method facilitates fast identification of key regulators, give raise to the possibility of higher successful conversion rate and in the hope of reducing experimental cost.
Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, and MAIA
Miguel, Jesús F. San , Usmani, Saad Z. , Paiva, Bruno , Plesner, Torben , Hungria, Vânia , Moreau, Philippe , Mateos, María‐Victoria , Perrot, Aurore , Iida, Shinsuke , Kumar, Shaji , Donk, Niels W.C.J. van de , Sonneveld, Pieter , Spencer, Andrew , Krevvata, Maria, Heuck, Christoph, Wang, Jianping , Ukropec, Jon, Kobos, Rachel, Sun, Steven , Qi, Mia, Munshi, Nikhil C. , San-Miguel, Jesus , Paiva, Bruno , Hungria, Vania , Mateos, María-Victoria , Perrot, Aurore , Iida, Shinsuke , Kumar, Shaji K , Moreau, Philippe , Usmani, Saad , Cavo, Michèle , Weisel, Katja C , Dimopoulos, Meletios Α. , Avet‐Loiseau, Hervé , Bahlis, Nizar Jacques , Facon, Thierry T.F.

Mayo Clinic

Blood | July 21, 2021 | Volume: 139 | Issue: 6 | Pages: 835-844

10.1182/blood.2021011101 | PMID 34289038 Get It

Abstract We explored minimal residual disease (MRD) in relapsed/refractory multiple myeloma (RRMM) and transplant-ineligible (TIE) newly diagnosed multiple myeloma (NDMM) using data from 4 phase 3 studies (POLLUX, CASTOR, ALCYONE, and MAIA). Each study previously demonstrated that daratumumab-based therapies improved MRD negativity rates and reduced the risk of disease progression or death by approximately half vs standards of care. We conducted a large-scale pooled analysis for associations between patients achieving complete response or better (≥CR) with MRD-negative status and progression-free survival (PFS). MRD was assessed via next-generation sequencing (10−5 sensitivity threshold). Patient-level data were pooled from all 4 studies and for patients with TIE NDMM and patients with RRMM who received ≤2 prior lines of therapy (≤2 PL). PFS was evaluated by response and MRD status. Median follow-up (months) was 54.8 for POLLUX, 50.2 for CASTOR, 40.1 for ALCYONE, and 36.4 for MAIA. Patients who achieved ≥CR and MRD negativity had improved PFS vs those who failed to reach CR or were MRD positive (TIE NDMM and RRMM hazard ratio [HR] 0.20, P < .0001; TIE NDMM and RRMM ≤2 PL HR 0.20, P < .0001). This benefit occurred irrespective of therapy or disease setting. A time-varying Cox proportional hazard model confirmed that ≥CR with MRD negativity was associated with improved PFS. Daratumumab-based treatment was associated with more patients reaching ≥CR and MRD negativity. These findings represent the first large-scale analysis with robust methodology to support ≥CR with MRD negativity as a prognostic factor for PFS in RRMM and TIE NDMM. These trials were registered at www.clinicaltrials.gov as #NCT02076009, #NCT02136134, #NCT02195479, and #NCT02252172.
Remarkable stability in clonal hematopoiesis involving leukemia‐driver genes in patients without underlying myeloid neoplasms
Kusne, Yael , Mangaonkar, Abhishek A. , Tefferi, Ayalew , Gangat, Naseema , Finke, Christy M. , Binder, Moritz , Patnaik, Mrinal M. , Mangaonkar, Abhishek A. , Tefferi, Ayalew , Binder, Moritz , Patnaik, Mrinal , Lasho, Terra L. , Chia, Nicholas

Mayo Clinic

American Journal of Hematology | July 21, 2021 | Volume: 96 | Issue: 10 | Pages: No page available

10.1002/ajh.26297 | PMID 34289145 Get It

Comments on Computed Tomography for Evaluating Appendicitis
Jordan, David W. , Dauer, Lawrence T. , McCollough, Cynthia H.

Mayo Clinic

JAMA Surgery | July 21, 2021 | Volume: 156 | Issue: 11 | Pages: 1072

10.1001/jamasurg.2021.3207 | PMID 34287643 Get It

Gas in the kidney: a case of emphysematous pyelonephritis in a patient with uncontrolled diabetes mellitus
Wahab, Abdul , Hayat, Muhammad Hashim , Yousaf, Amman , Tariq, Raseen , Tariq, Raseen , Wahab, Abdul

Mayo Clinic

BMJ Case Reports | July 21, 2021 | Volume: 14 | Issue: 7 | Pages: e243891

10.1136/bcr-2021-243891 | PMID 34290029 Get It